Robert A.. Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert A.. Schwartz has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
W. Clark Lambert
From Dermatology, Infectious Diseases and Pathology, New Jersey Medical School, Newark, New Jersey, USA
10 shared publicationsAnthony J. Papadopoulos
From Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey
5 shared publications- Camila Krysicka Janniger
New Jersey Medical School, Newark 07103-2714
5 shared publications Isabelle Thomas
5 shared publicationsJanet Vafaie
Department of Dermatology, UMDNJ-New Jersey Medical School, Newark, New Jersey, USA
3 shared publicationsJoseph A. Samady
From the Departments of Dermatology, Surgery, and Pathology, New Jersey Medical School, Newark, New Jersey, USA
3 shared publications
Latest Publications
- 22 December 2010
- Published by Wiley in Journal of Surgical Oncology
- Vol. 103 (2) , 193-195
Marjolin's warty ulcer
Marjolin's ulcer refers to malignant change within burn scar. The French surgeon Jean‐Nicolas Marjolin is honored with the eponym. Marjolin described the “warty ulcer” in the first edition of Dictionnaire de Medécine. In his description, Marjolin did not actually state that this ulcer represented malignant transformation. Credit for noting the specific association involved in Marjolin's ulcer belongs to Caesar Hawkins, an English Surgeon, who described skin cancer arising in burn and flogging scars. J. Surg. Oncol. 2011; 103:193–195.
- 22 December 2010
- Published by Wiley in Journal of Surgical Oncology
- Vol. 103 (2) , 193-195
Marjolin's warty ulcer
Marjolin's ulcer refers to malignant change within burn scar. The French surgeon Jean‐Nicolas Marjolin is honored with the eponym. Marjolin described the “warty ulcer” in the first edition of Dictionnaire de Medécine. In his description, Marjolin did not actually state that this ulcer represented malignant transformation. Credit for noting the specific association involved in Marjolin's ulcer belongs to Caesar Hawkins, an English Surgeon, who described skin cancer arising in burn and flogging scars. J. Surg. Oncol. 2011; 103:193–195.
- 25 November 2008
- Published by Wiley in International Journal of Dermatology
- Vol. 47 (12) , 1263-1270
Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome
Leishmaniasis is an emerging disease in HIV‐infected persons; visceral leishmaniasis is an AIDS‐defining opportunistic infection. The parasite that causes this infection is usually transmitted by the sandfly and occasionally by nonsterile needles among intravenous drug users. Diffuse cutaneous leishmaniasis (DCL) is a rare anergic variant of leishmanial infection with the characteristic presentation of numerous nonulcerating nodules with an abundant parasite load, lack of visceral involvement, negative reaction to the leishmanin skin test, and a chronic course with incomplete response to treatment and frequent relapses. We report a case of DCL that developed in the context of the immune reconstitution inflammatory syndrome (IRIS) in a man with AIDS following initiation of antiretroviral therapy. We also review DCL to emphasize the importance of recognizing and treating this evolving disease in the growing population of patients on immunorestorative therapy.
- 25 November 2008
- Published by Wiley in International Journal of Dermatology
- Vol. 47 (12) , 1263-1270
Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome
Leishmaniasis is an emerging disease in HIV‐infected persons; visceral leishmaniasis is an AIDS‐defining opportunistic infection. The parasite that causes this infection is usually transmitted by the sandfly and occasionally by nonsterile needles among intravenous drug users. Diffuse cutaneous leishmaniasis (DCL) is a rare anergic variant of leishmanial infection with the characteristic presentation of numerous nonulcerating nodules with an abundant parasite load, lack of visceral involvement, negative reaction to the leishmanin skin test, and a chronic course with incomplete response to treatment and frequent relapses. We report a case of DCL that developed in the context of the immune reconstitution inflammatory syndrome (IRIS) in a man with AIDS following initiation of antiretroviral therapy. We also review DCL to emphasize the importance of recognizing and treating this evolving disease in the growing population of patients on immunorestorative therapy.
- 20 January 2006
- Published by Wiley in International Journal of Dermatology
- Vol. 45 (2) , 93-99
Childhood molluscum contagiosum
- 20 January 2006
- Published by Wiley in International Journal of Dermatology
- Vol. 45 (2) , 93-99
Childhood molluscum contagiosum
- 1 August 2005
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 9 (4) , 159-161
Erythema Infectiosum
Background: Erythema infectiosum (fifth disease) is a common benign pediatric condition caused by B19 parvovirus. It can be identified clinically by a “slapped cheek” appearance that is often followed by reticulated exanthem on the trunk and extremities. Objective: This review article provides a concise overview of erythema infectiosum. Methods: The article is divided into the followings sections: background, epidemiologic characteristics, clinical description, diagnosis, differential diagnosis, laboratory diagnosis, prognosis, and management. Results: Erythema infectiosum is found to cause a fairly prominent classic rash and generalized symptoms. Conclusion: Although erythema infectiosum has many distinctive symptoms, the prognosis is excellent because the condition in children is usually self-limited.
- 1 August 2005
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 9 (4) , 159-161
Erythema Infectiosum
Background: Erythema infectiosum (fifth disease) is a common benign pediatric condition caused by B19 parvovirus. It can be identified clinically by a “slapped cheek” appearance that is often followed by reticulated exanthem on the trunk and extremities. Objective: This review article provides a concise overview of erythema infectiosum. Methods: The article is divided into the followings sections: background, epidemiologic characteristics, clinical description, diagnosis, differential diagnosis, laboratory diagnosis, prognosis, and management. Results: Erythema infectiosum is found to cause a fairly prominent classic rash and generalized symptoms. Conclusion: Although erythema infectiosum has many distinctive symptoms, the prognosis is excellent because the condition in children is usually self-limited.
- 1 June 2005
- Vol. 14 (2) , 69-74
The New Jersey Medical School.
The New Jersey Medical School (NJMS) was the first medical school in the state of New Jersey. Its creation required the vision and support of many, including a group of leaders at the Jersey City Medical Center, century old Seton Hall University and the Archdiocese of Newark. Chartered in 1954 as Seton Hall College of Medicine, it opened its doors in Jersey City in 1956. It was renamed as the New Jersey College of Medicine (1965-1970), and since 1970 as New Jersey Medical School.
- 1 June 2005
- Vol. 14 (2) , 69-74
The New Jersey Medical School.
The New Jersey Medical School (NJMS) was the first medical school in the state of New Jersey. Its creation required the vision and support of many, including a group of leaders at the Jersey City Medical Center, century old Seton Hall University and the Archdiocese of Newark. Chartered in 1954 as Seton Hall College of Medicine, it opened its doors in Jersey City in 1956. It was renamed as the New Jersey College of Medicine (1965-1970), and since 1970 as New Jersey Medical School.
- 30 March 2005
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (4) , 299-301
Lupus vulgaris: report of two cases
Although there has been a steady decline in the incidence of tuberculosis in recent years, it persists in some regions, and where AIDS is especially prevalent, the number of new cases has been increasing. 1-3 Thus, cutaneous tuberculosis has re‐emerged in areas with a high incidence of HIV infection and multidrug‐resistant pulmonary tuberculosis. Lupus vulgaris has been and remains the most common form of cutaneous tuberculosis. 1 Cutaneous manifestations of disseminated tuberculosis are unusual, being seen in less than 0.5% of cases. 4 Scrofuloderma, tuberculosis verrucosa cutis and lupus vulgaris comprise most cutaneous tuberculosis cases. 2 Bacillus Calmette‐Guérin (BCG) is derived from an attenuated strain of Mycobacterium bovis and is employed beneficially as a relatively safe vaccination in Poland and other countries in which the prevalence of tuberculosis is high. 5-10 However, BCG vaccination may produce complications, including disseminated BCG and lupus vulgaris, the latter seen in one of our two patients in whom lupus vulgaris at the inoculation site followed a second vaccination with BCG 12 years after the initial one. 1 A similar phenomenon has been described after immunotherapy with BCG vaccination. 2 Re‐infection (secondary) inoculation cutaneous tuberculosis may also occur as a result of BCG vaccination, producing either lupus vulgaris or tuberculosis verrucosa cutis, probably depending upon the patient's degree of cell‐mediated immunity. However, most lupus vulgaris cases are not associated with vaccination with BCG, as occurred in our first patient. For those who do develop lupus vulgaris, it can be persistent for a long period, in some cases for many decades. 3, 6-8 In the second patient we describe a lengthy duration and cutaneous reactivation at distant sites after more than 40 years.
- 30 March 2005
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (4) , 299-301
Lupus vulgaris: report of two cases
Although there has been a steady decline in the incidence of tuberculosis in recent years, it persists in some regions, and where AIDS is especially prevalent, the number of new cases has been increasing. 1-3 Thus, cutaneous tuberculosis has re‐emerged in areas with a high incidence of HIV infection and multidrug‐resistant pulmonary tuberculosis. Lupus vulgaris has been and remains the most common form of cutaneous tuberculosis. 1 Cutaneous manifestations of disseminated tuberculosis are unusual, being seen in less than 0.5% of cases. 4 Scrofuloderma, tuberculosis verrucosa cutis and lupus vulgaris comprise most cutaneous tuberculosis cases. 2 Bacillus Calmette‐Guérin (BCG) is derived from an attenuated strain of Mycobacterium bovis and is employed beneficially as a relatively safe vaccination in Poland and other countries in which the prevalence of tuberculosis is high. 5-10 However, BCG vaccination may produce complications, including disseminated BCG and lupus vulgaris, the latter seen in one of our two patients in whom lupus vulgaris at the inoculation site followed a second vaccination with BCG 12 years after the initial one. 1 A similar phenomenon has been described after immunotherapy with BCG vaccination. 2 Re‐infection (secondary) inoculation cutaneous tuberculosis may also occur as a result of BCG vaccination, producing either lupus vulgaris or tuberculosis verrucosa cutis, probably depending upon the patient's degree of cell‐mediated immunity. However, most lupus vulgaris cases are not associated with vaccination with BCG, as occurred in our first patient. For those who do develop lupus vulgaris, it can be persistent for a long period, in some cases for many decades. 3, 6-8 In the second patient we describe a lengthy duration and cutaneous reactivation at distant sites after more than 40 years.
- 1 February 2005
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (2) , 91-94
Insect sting reactions to bees, wasps, and ants
Arthropod bites and stings are capable of inflicting injury, inciting allergic reactions, and transmitting systemic disease. Members of the Hymenoptera order are of particular importance because they are nearly ubiquitous in nature, and their stings may cause life-threatening allergic reactions. Stings from bees, wasps, and ants produce a variety of clinical and histological manifestations. Anaphylaxis following an insect sting is the most serious complication. For individuals with a specific allergy to Hymenoptera venom, immunotherapy may be a relatively safe and effective treatment option.
- 1 February 2005
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (2) , 91-94
Insect sting reactions to bees, wasps, and ants
Arthropod bites and stings are capable of inflicting injury, inciting allergic reactions, and transmitting systemic disease. Members of the Hymenoptera order are of particular importance because they are nearly ubiquitous in nature, and their stings may cause life-threatening allergic reactions. Stings from bees, wasps, and ants produce a variety of clinical and histological manifestations. Anaphylaxis following an insect sting is the most serious complication. For individuals with a specific allergy to Hymenoptera venom, immunotherapy may be a relatively safe and effective treatment option.
- Open Access
- 23 December 2004
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (1) , 1-6
Epidermolytic hyperkeratosis: a keratin 1 or 10 mutational event
Epidermolytic hyperkeratosis is an unusual type of ichthyosis. This inherited keratinization disorder is characterized clinically by erythema, blistering, and peeling shortly after birth. It may resolve and be replaced with thick scaling. It can lead to life‐threatening complications, such as sepsis. Histologically, there is a hyperkeratosis and vacuolar degeneration. Genetically, this is an autosomal dominant disease with complete penetrance; however, 50% are spontaneous mutations. The clinical phenotype is a result of alterations in the gene(s) for keratin 1 and/or 10. We review this disorder and its therapy, which is mainly symptomatic with emollients and retinoids.
- 23 December 2004
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (1) , 1-6
Open AccessEpidermolytic hyperkeratosis: a keratin 1 or 10 mutational event
Epidermolytic hyperkeratosis is an unusual type of ichthyosis. This inherited keratinization disorder is characterized clinically by erythema, blistering, and peeling shortly after birth. It may resolve and be replaced with thick scaling. It can lead to life‐threatening complications, such as sepsis. Histologically, there is a hyperkeratosis and vacuolar degeneration. Genetically, this is an autosomal dominant disease with complete penetrance; however, 50% are spontaneous mutations. The clinical phenotype is a result of alterations in the gene(s) for keratin 1 and/or 10. We review this disorder and its therapy, which is mainly symptomatic with emollients and retinoids.
- 1 September 2004
- Published by Elsevier in The Lancet
- Vol. 364 (9440) , 1173-1182
Superficial fungal infections
- 1 September 2004
- Published by Elsevier in The Lancet
- Vol. 364 (9440) , 1173-1182
Superficial fungal infections
- 23 August 2004
- Published by Wiley in Journal of Surgical Oncology
- Vol. 87 (3) , 146-151
Kaposi's sarcoma: An update
While there have been many important advances in the study of Kaposi's sarcoma (KS), it remains both a challenge and an enigma in many ways. Kaposi's original description of “multiple idiopathic hemorrhagic sarcoma[s]” in patients who died within 2–3 years resembles KS in AIDS more than classic KS in elderly men of Italian, Jewish, or Mediterranean lineage, in whom the disease is usually benign. KS had been evident in about one‐third of those with early AIDS, often as its presenting sign, a pattern markedly reduced in recent times since the introduction of highly active anti‐retroviral therapy (HAART). The most important advance has been the convincing etiologic linkage of KS with human herpesvirus 8 (HHV‐8), which is necessary but not sufficient. It has a low prevalence in the general population of the USA and UK, with an intermediate rate in Italy and Greece, and a high one in Uganda. KS risk may be significantly lower in AIDS patients with a history of anti‐herpes therapy. Many aspects of HHV‐8, including its transmission pattern and different genospecies, are being scrutinized. The diagnosis of KS may be difficult. One should be aware of KS clinical variants, including telangiectatic, eccymotic, and keloidal KS. One must consider a number of other disorders, including bacillary angiomatosis. HHV‐8 DNA sequences in dermatofibromas and other tumors should probably not be viewed as representing a marker for KS. Therapeutic options vary for KS. Intralesional and low‐dose outpatient intravenous vinblastine may be valuable, as immunosuppression with KS is not a good idea if it can be avoided. Anti‐herpes virus therapy may have potential for wide use, especially in preventing the development of KS in at risk populations, such as HHV‐8 seropositive individuals undergoing transplantation surgery. J. Surg. Oncol. 2004;87:146–151.
- 23 August 2004
- Published by Wiley in Journal of Surgical Oncology
- Vol. 87 (3) , 146-151
Kaposi's sarcoma: An update
While there have been many important advances in the study of Kaposi's sarcoma (KS), it remains both a challenge and an enigma in many ways. Kaposi's original description of “multiple idiopathic hemorrhagic sarcoma[s]” in patients who died within 2–3 years resembles KS in AIDS more than classic KS in elderly men of Italian, Jewish, or Mediterranean lineage, in whom the disease is usually benign. KS had been evident in about one‐third of those with early AIDS, often as its presenting sign, a pattern markedly reduced in recent times since the introduction of highly active anti‐retroviral therapy (HAART). The most important advance has been the convincing etiologic linkage of KS with human herpesvirus 8 (HHV‐8), which is necessary but not sufficient. It has a low prevalence in the general population of the USA and UK, with an intermediate rate in Italy and Greece, and a high one in Uganda. KS risk may be significantly lower in AIDS patients with a history of anti‐herpes therapy. Many aspects of HHV‐8, including its transmission pattern and different genospecies, are being scrutinized. The diagnosis of KS may be difficult. One should be aware of KS clinical variants, including telangiectatic, eccymotic, and keloidal KS. One must consider a number of other disorders, including bacillary angiomatosis. HHV‐8 DNA sequences in dermatofibromas and other tumors should probably not be viewed as representing a marker for KS. Therapeutic options vary for KS. Intralesional and low‐dose outpatient intravenous vinblastine may be valuable, as immunosuppression with KS is not a good idea if it can be avoided. Anti‐herpes virus therapy may have potential for wide use, especially in preventing the development of KS in at risk populations, such as HHV‐8 seropositive individuals undergoing transplantation surgery. J. Surg. Oncol. 2004;87:146–151.